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ABSTRACT 
Cerebrovascular pathology is closely coupled to cognitive function decline, as indicated by numerous studies at the 
system level. To better understand the mechanisms of this cognitive decline it is important to resolve how pathological 
changes in the vasculature - such as perivascular plaques – affect local cerebral blood flow dynamics. This issue is 
ideally studied in the intact brain at very high spatial resolution.  
Here, we describe initial results obtained by an approach based on in vivo observation by multi-photon microscopy of 
vascular plaques and local blood flow measurements in a transgenic mouse model engineered to express the human 
amyloid precursor protein with the Swedish and Arctic mutations. These mice exhibit a striking abundance of 
perivascular plaques in the cerebral cortex and are well suited to investigate vascular pathology in Alzheimer's disease. 
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1. INTRODUCTION 
Cerebrovascular pathology is closely coupled to cognitive dysfunction, as indicated by numerous studies at system 
level1. Cerebral amyloid angiopathy (CAA) is a term used to describe the pathological changes occurring in cerebral 
blood vessels, resulting from deposition of amyloid proteins2. The term “amyloid” describes highly insoluble fibrils 
consisting of proteins rich in beta-pleated sheet secondary structure. Many amyloidogenic proteins are known and 
several staining methods are commonly used, such as dye substances named “Thioflavin S” or “Thioflavin T” 
(substances “T 1892” or “T 3516” Sigma-Aldrich Corporation, St. Louis, MO, USA) or “Methoxy-X04”3. These staining 
methods are specific for amyloid, as they have affinity for the beta-sheet content of amyloid. In addition, there are 
several commercially available antibodies that recognize the amyloidogenic protein and that distinguish between various 
fibrillar forms composed of Aβ and nonfibrillar Aβ. The severity of CAA depends on the deposition of Aβ. Diffuse 
periarterial deposits lacking a well defined border are common around capillaries and arterioles. The deposits are often in 
continuity with Aβ deposits in the adjacent neuropil and leave the endothelial cells intact. With increasing severity, Aβ 
infiltrates all layers of the vessel wall and disrupts the vascular architecture4. 
The local impact that  pathological changes in the vasculature, such as perivascular plaques, exert on cerebral blood flow 
dynamics, and ultimately, on neural function is poorly understood and is ideally studied in the intact brain at very high 
spatial resolution. Here, we describe initial results obtained by an approach which uses in vivo observation of vascular 
Aβ deposits and local blood flow measurements in a transgenic Alzheimer mouse model characterized by a striking 
abundance of  both intracortical and perivascular plaques. 
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 2. MATERIALS AND METHODS 
2.1. Animals 
As a model for Alzheimer’s disease (AD) we utilized 12-16 months old mice engineered to express the human amyloid 
precursor protein5 with the Swedish and Arctic mutations (APPArcSwe), displaying parenchymal and cerebrovascular 
amyloid deposits.. Young (3-6 months) and aged (around 16 months) C57BL/6 mice (Jackson Labs) served as control 
animals for optimizing staining protocols. In total, 13 animals of either sex were used. Surgery and preparation was 
performed as described earlier6. All experimental protocols were approved by the Institutional Animal Care and Use 
Committee and conform to the national guidelines for the care and use of animals. The number of animals used was kept 
at a minimum. 
2.2 In vivo imaging, data acquisition and analysis 
For in vivo imaging, a customized two-photon platform for in vivo imaging in mice as described earlier6 was used. 
Briefly, a model “FV300” laser scanning unit was mounted on a model BX51WI microscope (both Olympus Corp. 
Tokyo, Japan), and the light detecting photomultiplier tube, model R7683, a high efficiency OEM version of model 
R3896, was mounted in model C9143 Peltier cooling box equipped with a model C9145 DP-Type socket (all by 
Hamamatsu Photonics KK, Hamamatsu City, Japan) including a Cockroft-Walton style high DC voltqage source. The 
laser system was a model “Verdi 5W” / “Mira 900F” Nd:YVO4 / Ti:Sap unit (Coherent, Inc., Santa Clara, CA, USA). 
The beam of the Ti:Sap laser was controlled by means of a model “LM 0202P 5W IR / LIV8” Electro Optic Modulator 
system (Gsaenger / Linos, Planegg, FRG). The software package “Fluoview w/ O3D w/ TIEMPO, vs. 5.0 Build 107” 
(Olympus Corp. Tokyo, Japan) was used to control the scanning procedures (frame scans and line scans).  
Plaques had been stained with Thioflavine S or Thiofalvine T, applied to the exposed cortex, or Methoxy-X04, injected 
subcutaneously 24h in advance. For blood flow measurements, the blood plasma was labeled by intravenous injection of 
dextrane-coupled fluorescent dyes (Tetramethylrhodamineisothyocyanate - abbreviated “TRITC” - , dextran 3000MW, 
substance “D-3307”, Invitrogen / Molecular Probes, Eugene, OR, USA). Subsequently, dynamic intensity measurements 
were performed by line scanning and 3D image stacks were acquired. Visualization of plaques around blood vessels was 
done at 860 nm excitation. This wavelength is suitable for both, Thioflavine S or T or Methoxy excitation and TRITC 
excitation. Fluorescence was detected via model “HQ 460/50M-2p” (Methoxy-04 and Thioflavins) or “E680sp-2p” (D-
3307) fluorescence filters (Chroma Technology Corp, Rockingham, VT, USA). The transmission band of the former 
filter is from 435nm to 485nm, the latter is a broad band short pass filter transmitting the visible part of the spectrum and 
effectively blocking any wavelengths emitted by the Ti:Sap laser. Images at the different spectra were recorded 
consecutively and treated as individual channels during analysis. Image analysis, including 3D reconstructions and 
analysis of line scan data was performed off-line by means of software packages “Imaris, version 6.0” (Bitplane AG, 
Zürich, Switzerland), “ImageJ” 7, home made software in C and UNIX shell scripts for the extraction of time series data 
from line scan images (PJH), and software package “Origin” 7.5, OriginLab Corporation, Northampton, MA, USA, for 
the statistical analysis). 
2.3 Histology 
The animals used for in vivo imaging were transcardially perfused and processed for immunohistochemistry. In brief; we 
used 4% formaldehyde in sodium phosphate buffer. The brains were kept in the fixative overnight. Series of horizontal 
sections were cut on a Vibratome. The sections were immunohistochemically stained for amyloid using the polyclonal 
“Aβ42” antibody8 or “6E10” (Signet Laboratories Inc, MA, USA). Sections were developed with diaminobenzidine 
(DAB) substrate using the avidin-biotin horseradish peroxidase system (Vector Labs). 
 
 3. RESULTS 
3.1 Amyloid plaque deposition 
 
Figure 1. In vivo imaging of Thioflavin stained plaques in AD transgenic mice (a, scale bar 50 
micron upper part and 20 micron lower part) versus wild type (b, scale bar 20 micron). 
In vivo imaging revealed prominent staining representing perivascular plaques around some, but not all cerebral vessels 
in aged APPArcSwe animals, both using Thioflavine (Figure 1a) and Methoxy-X04 (Figure 2). Even in aged control 
animals, some vessels - presumably arterioles - exhibited striking Thioflavin positive material. The staining in control 
animals might represent arteriosclerotic plaques (Figure 1b). No Thioflavin staining was found in young control animals 
(not shown).  
Immunocytochemistry confirms the findings obtained in vivo concerning the abundance and distribution of plaques 




Figure 2. In vivo staining 
and 3D reconstruction of 
perivascular plaques and 
blood vessels in AD 
transgenic animals. Shown 
are examples of methoxy-
X04 positive structures 
surrounding big vessels (a, 
white structures, scale bar 
50μm), capillaries (b, scale 
bar 10 μm), and an 
example of reconstructed 
capillaries illustrating a site 
(blue cross) where blood 
flow measurements were 
taken (c, scale bar 50 μm). 
 
 
Figure 3. Aβ-ir plaque 
distribution in 16-month-
old mice with the Artic and 
Swedish Alzheimer 
mutations. Panel A shows 
an overview of cortical 
distribution of Aβ deposits. 
In panel B, perivascular 
amyloid is observed close 
to the cortical surface. The 
framed vessel in B is 
magnified in panel D. An 
age-matched non-
transgenic mouse is 
pictured in panel C. 
Cortex(Cx), Caudate 
Putamen (CPu). Scale bars: 
A 0.65mm, B 0.16mm, D 
0.08mm 
 
 3.2 Blood flow 
Initial analysis of blood flow measurements did not reveal any difference between AD transgenic animals (n=4) and 
control animals (n=3) under base line activity, as shown in Figure 4. This preliminary data set comprises one measured 
site per animal. 
 
Figure 4. Local blood 
flow in AD transgenic 
versus control animals. 
FFT analysis of line 
scan data, individual 
measurements (left) and 
group average (right), 
(transgenic, n=4; 
control, n=3; error bars 
indicate standard error 
of the mean). 
 
4. DISCUSSION 
The combination of in vivo multi-photon laser scanning microscopy (MPLSM) and fluorescent amyloid staining of 
perivascular plaques in aged APPArcSwe mice, as a model of Alzheimer's disease, permits analyses of the local impact 
of perivascular plaques on blood flow dynamics. In vivo application using methoxy-X04 yields a robust staining of 
plaques, including deposits on larger vessels and capillaries, as indicated by our comparison of in vivo and in vitro data. 
The animals displayed high frequency of extracellular plaques, including cerebrovascular amyloid deposits when 
examined with histochemical techniques. The Arctic mutation is unique among APP mutation, since it is located inside 
the Aβ domain and leads to AD. It thereby alters the fibrillogenic characteristics of Aβ peptides resulting e.g. in more 
rapid Aβ protofibril formation. Although CAA is seen in postmortem brain from mutation carriers, it is not considered as 
a model of CAA. However, we have chosen to work with this model since it produces Aβ protofibrils which constitute a 
form of large soluble Aβ aggregates that is considered particularly toxic to the microenvironment. Mice with the Arctic 
mutation also develop intraneuronal Aβ early in their life. Already within the first two month aggregates of Aβ is 
observed. The relatively high load of perivascular amyloid could be assumed to affect local blood flow, by compressing 
the capillaries or reducing the flexibility of these. However, we were not able to observe differences in local blood flow 
between AD transgenic animals and control animals. Our data set, however, is preliminary and is currently extended to 
include analyses of activity dependent blood flow changes in response to sensory stimulation 
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